Recital 2, Regulation (EU) 2018/588

In forcesince 18 Apr 2018

The Netherlands based its hazard assessment of NMP on the effects of the substance on several human health endpoints. Developmental toxicity was considered the most critical of those endpoints and was used to determine a level (the derived no-effect level or ‘DNEL’) above which workers should not be exposed to NMP by inhalation.